Bavarian Nordic is an international biotechnology headquartered in Denmark. Read the full story
Bavarian Nordic is an international biotechnology headquartered in Denmark. Read the full story
ARTES Biotechnology and Burnet Institute have joined forces to develop a new type of malaria vaccine in a project funded by the PATH Malaria Vaccine Initiative (MVI). Read the full story
MicuRx Pharmaceuticals announced it raised $25 million in Series B financing. Read the full story
3-V Biosciences announced the completion of a Series C financing round, raising $20 million. Read the full story
The Malaria Partnering provides understanding and access to the malaria partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story
The Dengue Fever Partnering provides understanding and access to the dengue fever partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story
The Tropical Diseases Partnering provides understanding and access to the tropical diseases partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story
The Fungal Partnering provides understanding and access to the fungal partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story
The Parasitic Partnering provides understanding and access to the parasitic partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story
The RSV Partnering provides understanding and access to the RSV partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story